Humana Inc. (NYSE:HUM) Shares Purchased by OLD National Bancorp IN

OLD National Bancorp IN boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 7.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,797 shares of the insurance provider’s stock after purchasing an additional 184 shares during the period. OLD National Bancorp IN’s holdings in Humana were worth $710,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Atlas Brown Inc. raised its stake in shares of Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after buying an additional 38 shares during the last quarter. Moors & Cabot Inc. raised its position in Humana by 2.5% during the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after acquiring an additional 40 shares in the last quarter. Your Advocates Ltd. LLP lifted its holdings in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the period. Brooklyn Investment Group boosted its position in Humana by 6.7% in the 3rd quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider’s stock worth $233,000 after purchasing an additional 46 shares in the last quarter. Finally, Demars Financial Group LLC grew its stake in shares of Humana by 2.7% during the 3rd quarter. Demars Financial Group LLC now owns 1,950 shares of the insurance provider’s stock worth $618,000 after purchasing an additional 52 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.32% of the company’s stock.

Humana Trading Down 1.2 %

NYSE HUM opened at $293.40 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $35.33 billion, a P/E ratio of 25.99, a PEG ratio of 2.22 and a beta of 0.55. The firm’s 50-day moving average is $275.45 and its two-hundred day moving average is $303.03. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. On average, sell-side analysts anticipate that Humana Inc. will post 16.11 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Wells Fargo & Company decreased their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Truist Financial upped their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. KeyCorp assumed coverage on Humana in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Royal Bank of Canada cut their price target on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, UBS Group lowered their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $297.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.